Division of Neurocritical Care, Departments of Neurology and Neurosurgery, NYU Langone Medical Center, 530 First Avenue, Skirball-7R, New York, NY, 10016, USA.
Neurocrit Care. 2024 Jun;40(3):1045-1058. doi: 10.1007/s12028-023-01872-5. Epub 2023 Oct 26.
The Uniform Law Commission paused work of the Drafting Committee to Revise the Uniform Determination of Death Act (UDDA) in September 2023.
Thematic review was performed of comments submitted to the Uniform Law Commission by medical organizations (MO), organ procurement organizations (OPO), and advocacy organizations (AO) from 1/1/2023 to 7/31/2023.
Of comments from 41 organizations (22 AO, 15 MO, 4 OPO), 34 (83%) supported UDDA revision (50% OPO, 33% MO recommended against revision). The most comments addressed modifications to "all functions of the entire brain, including the brainstem" (31; 95% AO, 75% OPO, 47% MO), followed by irreversible versus permanent (25; 77% AO, 50% OPO, 40% MO), accommodation of brain death/death by neurologic criteria (BD/DNC) objections (23; 100% OPO, 80% MO, 32% AO), consent for BD/DNC evaluation (18; 75% OPO, 47% MO, 36% AO), "accepted medical standards" (13; 36% AO, 33% MO, 0% OPO), notification before BD/DNC evaluation (14; 100% OPO, 53% MO, 9% AO), time to gather before discontinuation of organ support after BD/DNC determination (12; 60% MO, 25% OPO, 9% AO), and BD/DNC examiner credential requirements (2; 13% MO, 0% AO, 0% OPO). The predominant themes were that the revised UDDA should include the term "irreversible" and shouldn't (1) stipulate specific medical guidelines, (2) require notification before BD/DNC evaluation, or (3) require time to gather before discontinuation of organ support after BD/DNC determination. Views on other topics were mixed, but MO and OPO generally advocated for the revised UDDA to take a functional approach to BD/DNC, not require consent for BD/DNC evaluation, and not require opt-out accommodation of BD/DNC objections. Contrastingly, many AO and some MO with religious affiliations or a focus on advocacy favored the revised UDDA take an anatomic approach to BD/DNC or eliminate BD/DNC altogether, require consent for BD/DNC evaluation, and require opt-out accommodation of BD/DNC objections.
Most commenting organizations support UDDA revision, but perspectives on the approach vary, so the Drafting Committee could not formulate revisions that would be agreeable to all stakeholders.
统一法律委员会于 2023 年 9 月暂停修订《统一死亡判定法》(UDDA)起草委员会的工作。
对 2023 年 1 月 1 日至 7 月 31 日期间各医学组织(MO)、器官获取组织(OPO)和倡导组织(AO)向统一法律委员会提交的评论进行主题审查。
在 41 个组织(22 个 AO、15 个 MO、4 个 OPO)的评论中,34 个(83%)支持 UDDA 修订(50% OPO、33% MO 反对修订)。大多数评论都涉及对“整个大脑的所有功能,包括脑干”的修改(31 条;95%的 AO、75%的 OPO、47%的 MO),其次是不可逆与永久(25 条;77%的 AO、50%的 OPO、40%的 MO)、对脑死亡/神经标准判定死亡(BD/DNC)异议的适应(23 条;100%的 OPO、80%的 MO、32%的 AO)、BD/DNC 评估同意(18 条;75%的 OPO、47%的 MO、36%的 AO)、“公认的医疗标准”(13 条;36%的 AO、33%的 MO、0%的 OPO)、BD/DNC 评估前通知(14 条;100%的 OPO、53%的 MO、9%的 AO)、BD/DNC 判定后器官支持停止前收集时间(12 条;60%的 MO、25%的 OPO、9%的 AO)以及 BD/DNC 审查员资格要求(2 条;13%的 MO、0%的 AO、0%的 OPO)。主要主题是,修订后的 UDDA 应包括“不可逆”一词,并且不应(1)规定具体的医疗指南,(2)要求 BD/DNC 评估前通知,或(3)要求在 BD/DNC 判定后器官支持停止前收集时间。其他主题的观点不一,但 MO 和 OPO 通常主张修订后的 UDDA 对 BD/DNC 采用功能方法,不要求 BD/DNC 评估同意,也不要求 BD/DNC 异议的默认同意。相比之下,许多 AO 和一些具有宗教背景或专注于倡导的 MO 赞成修订后的 UDDA 对 BD/DNC 采用解剖方法或完全消除 BD/DNC,要求 BD/DNC 评估同意,并要求默认同意 BD/DNC 异议。
大多数发表评论的组织支持修订 UDDA,但对方法的看法存在差异,因此起草委员会无法制定出所有利益相关者都同意的修订方案。